In multiple colorectal cancer (CRC) patient cohorts, we show that loss of NLRC4 protein expression specifically in the tumor, but not the stroma, is associated with aggressive metastatic progression, decreased patient survival, and lower DC and T cell immune infiltrates. Here, NLRC4 is linked to neoplasm.